Graphene oxide-microplastic hybrid showcase elicited discrepancy through intrinsic interaction mediated steatosis, and apoptosis in macrophages
Abstract
The widespread natural abundance of microplastics (MP) has been recognized to pose significant global health concerns, particularly due to limited understanding of their biological interactions. With the uncontrolled increase in MP accumulation in the environment, their interaction with xenobiotics like nanomaterials used for different biomedical and environmental applications is likely to be enhanced, raising concern over the advanced toxicological impacts. Hence, it is important to deduce their threatening toxicity to the biological niche, including humans. This study deduces the cytotoxicity of a green-synthesized GO@MP hybrid using macrophage cells, integrating experimental and computational methods. Physicochemical characterization was performed using FTIR, SEM, and DLS. Toxicological assessment revealed that GO@MP significantly reduced cell viability, primarily via surface adherence and deposition. Experimental analysis demonstrated concentration-dependent accumulation and internalization of GO and MP. Compared to individual MP and GO, the hybrid induced higher levels of lipid peroxidation and mitochondrial membrane damage, triggering enhanced apoptosis. In silico analysis indicated interactions between GO@MP and proteins involved in oxidative stress and apoptotic pathways for the molecular discrepancies. Computational modelling further unraveled atomic-level interactions between GO and MP with key metabolic and apoptotic proteins, including PEX5, PEX14, BCL2, and…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.